NeuroOne Medical Technologies CorpNMTC
Price$0.99

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $11.3M+33.6% YoYTTM through 31 Mar 2026
Net Income -$6.9MTTM through 31 Mar 2026
Free Cash Flow -$8.8MTTM through 31 Mar 2026

Margins

Current
Gross Margin53.7%
Operating Margin-128.1%
Net Margin-128.1%

Returns

-136.6%ROE
-95.4%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio2.60x
Net Debt-$2.8Mnet cash position
Cash & Equivalents$2.8M

Quality Metrics

FCF Margin-78.4%
Earnings-Beat Rate66.7%

Dividend

No dividend
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.